# Medtronic Inc. (NYSE: MDT), Mounds View, MN – FDA Inspections

Source: https://www.keypedia.com/companies/medtronic-inc/41386b1c-ad8d-48e3-ab53-fdfbdcab10aa

> Inspection records and compliance data for Medtronic Inc. in Mounds View, Minnesota. 17 FDA inspections on record (2 OAI), 3 Form 483s, last inspected February 10, 2025. Publicly traded as NYSE: MDT.

---

## Details

- Name: Medtronic Inc.
- FEI Number: 2182208
- Address Line 1: 8200 Coral Sea St Ne
- City: Mounds View
- State: Minnesota
- Zip Code: 55112
- Country Name: United States
- Address: 8200 Coral Sea St Ne, Mounds View, Minnesota 55112, United States
- Country: United States

## Stock

- Stock ticker: MDT
- Exchange: NYSE
- Share price: $100.98
- Market cap: $129.2B
- Price as of: November 13, 2026

## Related Documents

- [483 - Medtronic Inc. - 2025-02-10](https://www.keypedia.com/records/483/medtronic-inc/041f6c36-79f6-4504-a6d7-5e8ff9a71dbe) — source: FDA, date: February 10, 2025
- FDA Inspection 1250873 - Medtronic Inc. - 2025-02-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2025
- [FDA Inspection 1250873 - Medtronic Inc. - 2025-02-10](https://www.keypedia.com/records/fda_inspections/medtronic-inc/6bd08238-e256-47bf-b018-8c33f17fc60f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2025
- FDA Inspection 1250873 - Medtronic Inc. - 2025-02-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2025
- FDA Inspection 1250873 - Medtronic Inc. - 2025-02-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2025
- [FDA Inspection 1217414 - Medtronic Inc. - 2023-09-01](https://www.keypedia.com/records/fda_inspections/medtronic-inc/6f943200-ba29-4b5c-9d5c-470009a415b4) — classification: No Action Indicated (NAI), source: FDA, date: September 1, 2023
- FDA Inspection 1118989 - Medtronic Inc. - 2020-02-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 4, 2020
- [FDA Inspection 1157919 - Medtronic Inc. - 2018-08-16](https://www.keypedia.com/records/fda_inspections/medtronic-inc/9881dcb6-f964-495f-b5b0-257c8af85b16) — source: FDA, date: August 16, 2018
- [FDA Inspection 1052017 - Medtronic Inc. - 2018-05-14](https://www.keypedia.com/records/fda_inspections/medtronic-inc/fdca1d91-dbf2-4fae-95b0-2488ae45b8ff) — classification: Official Action Indicated (OAI), source: FDA, date: May 14, 2018
- FDA Inspection 1034329 - Medtronic Inc. - 2017-11-16 — source: FDA, date: November 16, 2017
- FDA Inspection 1029345 - Medtronic Inc. - 2017-08-30 — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2017

## Related Companies

- [Abbott Vascular Inc](https://www.keypedia.com/companies/abbott-vascular-inc/e3cfce73-cc19-4e69-b30a-54dee1543d8a)
- [Physio-Control, Inc.](https://www.keypedia.com/companies/physio-control-inc/cd3b1656-c525-4cfe-a3f2-d32143e20c7c)
- [Omega Medical Imaging, Inc.](https://www.keypedia.com/companies/omega-medical-imaging-inc/74d04b67-394a-442a-b4f2-08d3f58760c3)
- [Ventana Medical Systems, Inc.](https://www.keypedia.com/companies/ventana-medical-systems-inc/fbee7b78-8ed8-4956-853d-aae637e77eab)
- [AngioDynamics, Inc.](https://www.keypedia.com/companies/angiodynamics-inc/1bc90c7f-6a45-49ef-a2a5-fc38418e84aa)
- [Boston Scientific Corporation](https://www.keypedia.com/companies/boston-scientific-corporation/7b03f40b-d516-4bcb-9702-929c6f485000)
- [Abbott](https://www.keypedia.com/companies/abbott/b7d5749c-5854-4f4a-ad2f-fd6002f0d9fe)
- [Edwards Lifesciences, LLC](https://www.keypedia.com/companies/edwards-lifesciences-llc/33cf0071-5dab-4e01-8479-22f60c63e818)
- [Xintec Corp](https://www.keypedia.com/companies/xintec-corp/68cff15b-7e97-469a-bba5-602f16256f3f)
- [DSM Biomedical, Inc.](https://www.keypedia.com/companies/dsm-biomedical-inc/7a6db46d-6f3e-4e92-8fde-1d4f124bdc5e)

## Related Officers

- [investigator](https://www.keypedia.com/people/tyler-r-courtney/08ea96c4-cd5a-4793-b7e4-fb2b9ee2b9ef)
